Fast Establishment of Beneficial Microflora for Poultry Performance

The most prevalent issues in poultry industry are diseases (e.g. dysbiosis, coccidiosis, necrotic enteritis, lameness caused by Bacterial Chondronecrosis with Osteomyelitis (BCO), Gram-negative pathogens like E.coli), regulatory issues, food safety (e.g. Salmonellosis and Campylobacteriosis) and antibiotic growth promoter (AGP)-free poultry production.

The main objective in poultry production is to achieve high quality products at high levels of productivity. The key for producers to achieve this goal is to avoid bacterial challenges e.g. from feed, water, environment, gastrointestinal tract (GIT) and to mitigate mycotoxins. Doing so without the use of AGPs requires different strategies that focus on prevention and promote good gut performance.

Supplementation with the right probiotics favourably influences the microbial community in the gut, and aid the bird to establish or re-establish the state of eubiosis, thus enhancing gut health and productivity.

In general, the following modes of action of probiotics are proposed: 

1. competition with pathogenic bacteria for space, intestinal adhesion sites and nutrients (competitive exclusion);
2. enhancement of epithelial barrier integrity;
3. production of antimicrobial substances;
4. change of environmental conditions in the intestine by lowering of pH through increased production of acids;
5. enhancement of intestinal immune function (Source: Probiotics in Poultry Production 2014, Erber AG, Austria)

The main goal of probiotics is to influence the intestinal microflora in a positive way, either by promoting its development, maturation or stabilization. A well-established intestinal microflora is crucial for the health of our animals, especially if we expect high production performance. It is extremely important to the most for their ability to fight off infections with enteric pathogens and for guaranteeing a well-functioning end effective digestion of nutrients, resulting in good growth performance parameters.

The right probiotic bacterial strains block receptor sites in the intestinal wall, thus preventing pathogenic bacteria from establishing themselves in the gut. This principle is known as ‘competitive exclusion.’

These beneficial microbes produce lactic acid (and other metabolites, i.e. short chain fatty acids), that reduce the pH in the animal’s gut and make it less favorable for opportunistic/pathogenic bacteria to grow or proliferate.

Probiotic supplementation of the intestinal microflora will also enhance the gut barrier, primarily by preventing colonization by pathogens and by acting indirectly as adjuvant-like stimulation of innate and acquired immune functions. However, evidence for probiotic-mediated enhancement of immunity requires further research.